Didembourg M, David C, Morimont L, Cransquint E, Favresse J, Douxfils J
Heliyon. 2025; 11(1):e41249.
PMID: 39811280
PMC: 11729664.
DOI: 10.1016/j.heliyon.2024.e41249.
Favresse J, Tre-Hardy M, Gillot C, Cupaiolo R, Wilmet A, Beukinga I
Heliyon. 2024; 10(16):e36116.
PMID: 39247272
PMC: 11379571.
DOI: 10.1016/j.heliyon.2024.e36116.
Gillot C, Bayart J, Maloteau V, Dogne J, Douxfils J, Favresse J
Case Rep Infect Dis. 2024; 2024:9163490.
PMID: 39246664
PMC: 11380708.
DOI: 10.1155/2024/9163490.
Souiri A, Lemriss S, El Maliki B, Falahi H, El Fahime E, El Kabbaj S
Vaccines (Basel). 2023; 11(3).
PMID: 36992173
PMC: 10054367.
DOI: 10.3390/vaccines11030590.
Gdoura M, Ghaloum F, Hamida M, Chamsa W, Triki H, Bahloul C
Sci Rep. 2022; 12(1):11298.
PMID: 35788676
PMC: 9252535.
DOI: 10.1038/s41598-022-15378-1.
Total anti-SARS-CoV-2 antibodies measured 6 months after Pfizer-BioNTech COVID-19 vaccination in healthcare workers.
Salvagno G, Henry B, Pighi L, de N, Lippi G
J Med Biochem. 2022; 41(2):199-203.
PMID: 35510202
PMC: 9010038.
DOI: 10.5937/jomb0-33999.
Long-term decay of anti-RBD IgG titers after BNT162b2 vaccination is not mirrored by loss of neutralizing bioactivity against SARS-CoV-2.
Malipiero G, DAgaro P, Segat L, Moratto A, Villalta D
Clin Chim Acta. 2021; 524:11-17.
PMID: 34843705
PMC: 8630423.
DOI: 10.1016/j.cca.2021.11.023.
Dynamics of Neutralizing Antibody Responses Following Natural SARS-CoV-2 Infection and Correlation with Commercial Serologic Tests. A Reappraisal and Indirect Comparison with Vaccinated Subjects.
Gillot C, Favresse J, Maloteau V, Dogne J, Douxfils J
Viruses. 2021; 13(11).
PMID: 34835135
PMC: 8621742.
DOI: 10.3390/v13112329.
Alpha (B.1.1.7) and Delta (B.1.617.2 - AY.40) SARS-CoV-2 variants present strong neutralization decay at M4 post-vaccination and a faster replication rates than D614G (B.1) lineage.
Lebourgeois S, Menidjel R, Chenane H, Ferre V, Collin G, Damond F
J Infect. 2021; 84(3):418-467.
PMID: 34808243
PMC: 8603409.
DOI: 10.1016/j.jinf.2021.11.012.
Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare Workers.
Bayart J, Douxfils J, Gillot C, David C, Mullier F, Elsen M
Vaccines (Basel). 2021; 9(10).
PMID: 34696200
PMC: 8540417.
DOI: 10.3390/vaccines9101092.
Antibody titers and protection against a SARS-CoV-2 infection.
Dimeglio C, Herin F, Martin-Blondel G, Miedouge M, Izopet J
J Infect. 2021; 84(2):248-288.
PMID: 34560135
PMC: 8452591.
DOI: 10.1016/j.jinf.2021.09.013.
